David Seiffge

Has grant

Country flagSwitzerland

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Towards understanding mechanism and outcome of intracerebral haemorrhage in patients taking oral anticoagulants - insights from neuroimaging and genetics

Open Date: 2018-02-01

Close Date: 2019-01-31

Articles (21)

Background Posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) may cause ischaemic stroke and intracranial haemorrhage. The aim of our study was to assess the frequency of the afore‐mentioned outcomes. Methods We performed a PROSPERO‐registered (CRD42022355704) systematic review and meta‐analysis accessing PubMed until 7 November 2022. The inclusion criteria were: (1) original publication, (2) adult patients (≥18 years), (3) enrolling patients with PRES and/or RCVS, (4) English language and (5) outcome information. Outcomes were frequency of (1) ischaemic stroke and (2) intracranial haemorrhage, divided into subarachnoid haemorrhage (SAH) and intraparenchymal haemorrhage (IPH). The Cochrane Risk of Bias tool was used. Results We identified 848 studies and included 48 relevant studies after reviewing titles, abstracts and full text. We found 11 studies on RCVS (unselected patients), reporting on 2746 patients. Among the patients analysed, 15.9% (95% CI 9.6%–23.4%) had ischaemic stroke and 22.1% (95% CI 10%–39.6%) had intracranial haemorrhage. A further 20.3% (95% CI 11.2%–31.2%) had SAH and 6.7% (95% CI 3.6%–10.7%) had IPH. Furthermore, we found 28 studies on PRES (unselected patients), reporting on 1385 patients. Among the patients analysed, 11.2% (95% CI 7.9%–15%) had ischaemic stroke and 16.1% (95% CI 12.3%–20.3%) had intracranial haemorrhage. Further, 7% (95% CI 4.7%–9.9%) had SAH and 9.7% (95% CI 5.4%–15%) had IPH. Conclusions Intracranial haemorrhage and ischaemic stroke are common outcomes in PRES and RCVS. The frequency reported in the individual studies varied considerably.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (16)

Marco Pasi

Université de Lille

FRANCE
View details

Adrian Parry-Jones

The University of Manchester

UNITED KINGDOM
View details

Christoph Kurmann

University Hospital of Bern

SWITZERLAND
View details

Simon Jung

University Hospital of Bern

SWITZERLAND
View details

Mirjam R. Heldner

-

SWITZERLAND
View details

Jan Gralla

Head and Director, Full Professor

University of Bern

SWITZERLAND
View details

Stephen Makin

University of Aberdeen

UNITED KINGDOM
View details

Gargi Banerjee

Stroke Association & NIHR Clinical Lecturer

-

UNITED KINGDOM
View details

Bastian Volbers

University of Erlangen-Nuremberg

GERMANY
View details

Johannes Kaesmacher

-

SWITZERLAND
View details

Simon Fandler-Höfler

Medical University of Graz

AUSTRIA
View details

Lisa Herzog

Lecturer

Zurich University of Applied Sciences (ZHAW)

SWITZERLAND
View details

Nils Peters

University Hospital Basel

SWITZERLAND
View details

Lucas Heinrich Kook

University of Zurich

SWITZERLAND
View details

Ying Xian

University of Texas Southwestern Medical Center

UNITED STATES
View details

Alexandros Polymeris

University Hospital Basel

SWITZERLAND
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.